FLT1 and endothelial dysfunction: Metformin reduces insulin resistance, endothelial dysfunction, and hyperglycemia, and it may prevent the development of HDP by reducing the secretion of soluble fms-like tyrosine kinase-1 (sFlt-1) [18,19,20,21,22].